Today: 29 April 2026
Compass Group shares slide after Q1 sales beat, guidance held and USD trading switch flagged
5 February 2026
2 mins read

Compass Group shares slide after Q1 sales beat, guidance held and USD trading switch flagged

London, Feb 5, 2026, 09:28 GMT — Regular session

  • Shares in Compass Group dropped around 3% in early London trading following its first-quarter update
  • Organic revenue grew 7.3% this quarter, edging past the company-compiled consensus.
  • Investors are weighing plans to switch the stock’s London trading currency to U.S. dollars starting April 1

Shares of Compass Group (CPG.L) slipped roughly 3% to near 2,150 pence by 0923 GMT, erasing earlier gains following the release of the caterer’s Q1 trading update.

This move is significant since Compass has served as a reliable indicator for corporate outsourcing and venue footfall—both sectors that can shift rapidly when budgets shrink. It also arrives as investors reassess what counts as “good growth” now that inflation is easing and pricing power is less effective.

Compass reported a 7.3% rise in organic revenue for the quarter ending Dec. 31, slightly beating the consensus estimate of 7.1% compiled by the company. The growth was driven by strong demand in sports & leisure and business & industry sectors. North America, which accounts for nearly 70% of total revenue, continued its upward trend despite ongoing tariff and policy uncertainties.

Compass reported net new business growth remained steady within its 4%-5% target range, with client retention surpassing 96%. Annualised new business wins hit $4 billion, marking a 10% increase year on year. The company will shift the trading currency of its London-listed ordinary shares from sterling to U.S. dollars starting April 1, though its FTSE inclusion and London listing will stay intact. Dividends will continue to be paid in sterling unless shareholders opt for dollars. CEO Dominic Blakemore highlighted a “strong start to the year,” citing particularly strong momentum in business & industry across North America. TradingView

The stock fluctuated from roughly 2,037 pence up to 2,157 pence, closing lower than the prior 2,222 pence. The broader FTSE 100 edged up slightly during the session.

Some investors zeroed in on what Compass refrained from doing — it left its full-year forecast unchanged — instead of the slight beat in quarterly results. The company also pointed out that pricing “moderated” as inflation eased, which can dampen growth appearances even if volume remains steady.

Compass maintained its 2026 outlook, targeting roughly 7% organic revenue growth alongside about 10% growth in underlying operating profit on a constant currency basis. The constant currency approach uses fixed exchange rates to eliminate the impact of exchange rate fluctuations.

The move to change the trading currency is rare, though not unheard of, for multinationals heavily reliant on dollars. Compass described it as a step to cut down on foreign-exchange volatility in its share price and make the investment story clearer for international investors.

There’s a catch: a softer pricing environment could reveal weaknesses in volume. Meanwhile, the group is still working through the integration of its $1.7 billion Vermaat acquisition, finalized last December.

Traders are focused on today’s annual general meeting in London and the company’s “sectorisation” deep dive set for Feb. 9, where it will outline its strategy and provide more details on the Vermaat deal. After that, the next key date is April 1, when the switch in London trading currency is scheduled. Half-year results come later, on May 11.

Stock Market Today

  • April FOMC US Index Levels Update: Dow Jones, Nasdaq, S&P 500
    April 29, 2026, 1:36 PM EDT. Stocks face volatility ahead of key earnings reports from tech giants Meta, Alphabet, Amazon, and Microsoft after market close. Investors seek signs that massive infrastructure spending and AI investments, fueled by trillions of dollars, are generating expected returns. This scrutiny recalls the 2025 AI/Tech crash triggered by unmet high expectations. Meanwhile, geopolitical tensions persist as the US-Iran standoff affects the Strait of Hormuz, pushing oil prices above $105 per barrel. Elevated crude prices raise concerns over inflation and market stability. The market waits on April FOMC signals and intraday performance metrics for the Dow Jones, Nasdaq, and S&P 500 to gauge risk appetite amid these economic and geopolitical pressures.

Latest article

Dow Jones Today: Why The Dow Is Holding Up While Nasdaq Sinks On AI Worries

Dow Jones Today: Why the Blue-Chip Index Is Sliding Before Powell, Big Tech and the Oil Shock

29 April 2026
NEW YORK, April 29, 2026, 13:02 EDT The Dow Jones Industrial Average fell in early afternoon trading on Wednesday, down 320.11 points, or 0.65%, at 48,821.82, as investors cut risk before a Federal Reserve decision, major technology earnings and another jump in oil. The S&P 500 slipped 0.21% and the Nasdaq Composite lost 0.28%, while Brent crude rose 7.14% to $119.20, LSEG data carried by Reuters showed. That matters now because the Dow was on pace for a fifth straight decline, which would be its longest losing streak since Oct. 10, 2025, according to Dow Jones Market Data cited by
General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Singtel stock price slips after KKR’s $5.2 billion STT GDC deal — here’s what’s driving it
Previous Story

Singtel stock price slips after KKR’s $5.2 billion STT GDC deal — here’s what’s driving it

BAE Systems share price slides as buyback update lands and investors eye Feb 18 results
Next Story

BAE Systems share price slides as buyback update lands and investors eye Feb 18 results

Go toTop